Actively Recruiting
Association Between Stroke and Adrenal Incidentalomas
Led by Xuanwu Hospital, Beijing · Updated on 2022-02-14
2
Participants Needed
1
Research Sites
412 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Adrenal incidentalomas (AIs) are commonly encountered in transsection imaging which purpose not for suspected adrenal disease. However, part of AIs in patients is associated with Stroke. Stroke is a diseases which could cause of disability and death worldwide. In clinical practice, detailed information about the association between stroke and AIs is not available. In this study, the investigators aimed to investigate the risk for disability and death in the large group of stroke patients with AIs.
CONDITIONS
Official Title
Association Between Stroke and Adrenal Incidentalomas
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Stroke disease, such as cerebral infarction, intracerebral hemorrhage, and subarachnoid hemorrhage.
You will not qualify if you...
- Presence of metastatic cancer.
- Adrenal incidentalomas smaller than 1 cm.
- Nonadenoma lesions such as myelolipomas, hemorrhages, and cysts.
- Oral glucocorticoid treatment with more than a single dose in the past 3 months.
- Use of inhaled steroids or medications affecting dexamethasone metabolism.
- Systemic estrogen treatment.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hao Yan
Beijing, China, 100053
Actively Recruiting
Research Team
H
Hao Yan, Dr.
CONTACT
T
Tong W Ou, Dr.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here